Assesses antidiabetic effects of Tadehagi triquetrum extracts, indicating potential benefits for diabetes management.
Sixteen compounds were separated and purified from the petroleum ether and ethyl acetate extracts of Tadehagi triquetrum (L.) H.Ohashi (T. triquetrum) with hypoglycaemic activity. These included a new compound 1, and seven compounds isolated from T. triquetrum for the first time. The α-glucosidase inhibitory and glucose uptake-promoting effects of the isolates were assessed. Compounds 10, 1, and 7 exhibited strong α-glucosidase inhibitory activity, yielding IC50 figures of 1.89 ± 0.51 µM, 6.99 ± 0.74 µM, and 7.21 ± 0.66 µM, respectively. At the concentration of 20 μM, 5 and 6 markedly elevated glucose uptake in mature 3T3-L1 adipocytes, achieving uptake rates of 56.19% ± 1.66 and 50.54% ± 2.05, respectively. The α-glucosidase inhibitory effects of 1 and 2, and the glucose uptake activity of 5 and 6, are reported here for the first time. These findings emphasise the potential value of T. triquetrum in antidiabetic research.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: